It is a machinery and equipment public limited company based in Ahmadabad City, Gujarat, India, established in 2021.
2021 | Ahmadabad City, Gujarat, India | ActiveEris Therapeutics Limited, a active public limited company, was established on 23 June 2021 in Ahmadabad City, Gujarat, India. Engaging in industrial machinery manufacturing within the manufacturing sector, it holds CIN: U24230GJ2021PLC123519. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.01 Cr and a paid-up capital of ₹2.58 M.
Employing 611 professional, Its leadership includes Inderjeet Singh Negi (Director), Nita Prasad Borkar (Director), Sujesh Vasudevan (Additional Director). Past directors included Nita Prasad Borkar. It holds ₹555.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4Th Floor, A Wing, Shilp Accord,, Opposite Time Square Ii, Thaltej,, Ahmadabad City, Gujarat, 380054.
U24230GJ2021PLC123519
123519
23 June 2021
₹3.01 Cr
₹2.58 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Eris Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Inderjeet Singh Negi | Director | 23 Jun 2021 | Current |
| Nita Prasad Borkar | Director | 30 Jul 2024 | Current |
| Sujesh Vasudevan | Additional Director | 04 Jul 2025 | Current |
| Kaushal Kamlesh Shah | Director | 23 Jun 2021 | Current |
| Sachin Shah | Director | 23 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eris Therapeutics Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Eris Therapeutics had a promoter holding of 99.94% and a public holding of 0.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,550,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2025 | Sbicap Trustee Company Limited | ₹150.00 Cr | Open |
| 30 Nov 2024 | Hdfc Bank Limited | ₹100.00 Cr | Open |
| 15 Dec 2023 | Axis Bank Limited | ₹135.00 Cr | Open |
| 08 Aug 2022 | Citi Bank N.A. | ₹20.00 Cr | Open |
| 08 Aug 2022 | Citi Bank N.A. | ₹150.00 Cr | Open |
Explore comprehensive loan charge details -
Eris Therapeutics has a workforce of 611 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eris Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sujesh Vasudevan was appointed as a Additional Director was appointed as a Additional Director on 04 Jul 2025 & has been associated with this company since 4 months 26 days . was documented.
A charge with Sbicap Trustee Company Limited amounted to Rs. 150.00 Cr with Charge ID 101059789 was registered on 19 Feb 2025. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 100.00 Cr with Charge ID 101017877 was registered on 30 Nov 2024. was completed.
Eris Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Nita Prasad Borkar was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 1 year 4 months . was documented.
The activity Eris Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The CIN of Eris Therapeutics Limited is U24230GJ2021PLC123519.
Eris Therapeutics Limited is headquartered at 4Th Floor, A Wing, Shilp Accord,, Opposite Time Square Ii, Thaltej,, Ahmadabad City, Gujarat, 380054.
Eris Therapeutics Limited was incorporated on 23 June 2021.
The current directors of Eris Therapeutics Limited are
The primary industry of Eris Therapeutics Limited is Manufacturing.
Eris Therapeutics Limited is unlisted.
The authorized capital of Eris Therapeutics Limited is ₹3.01 Cr, and the paid-up capital is ₹2.58 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX